HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 17.77 Million USD | -41.64% |
| 2021 | 30.46 Million USD | -13.46% |
| 2020 | 35.19 Million USD | -21.99% |
| 2019 | 45.11 Million USD | 3.08% |
| 2018 | 43.77 Million USD | 105.92% |
| 2017 | 21.25 Million USD | 15.18% |
| 2016 | 18.45 Million USD | -53.22% |
| 2015 | 39.44 Million USD | 351.94% |
| 2014 | 8.72 Million USD | 98.47% |
| 2013 | 4.39 Million USD | -47.85% |
| 2012 | 8.43 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 10.86 Million USD | -38.88% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q1 | 28.46 Million USD | -6.55% |
| 2022 FY | 17.77 Million USD | -41.64% |
| 2022 Q2 | 22.2 Million USD | -21.99% |
| 2022 Q4 | 17.77 Million USD | 30.62% |
| 2022 Q3 | 13.61 Million USD | -38.71% |
| 2021 Q2 | 37.31 Million USD | 1.89% |
| 2021 Q1 | 36.62 Million USD | 4.06% |
| 2021 FY | 30.46 Million USD | -13.46% |
| 2021 Q3 | 34.5 Million USD | -7.54% |
| 2021 Q4 | 30.46 Million USD | -11.73% |
| 2020 Q4 | 35.19 Million USD | -4.12% |
| 2020 Q2 | 39.3 Million USD | -6.26% |
| 2020 Q1 | 41.92 Million USD | -7.08% |
| 2020 FY | 35.19 Million USD | -21.99% |
| 2020 Q3 | 36.71 Million USD | -6.6% |
| 2019 Q1 | 36.41 Million USD | -16.81% |
| 2019 Q4 | 45.11 Million USD | -11.41% |
| 2019 Q2 | 35.12 Million USD | -3.53% |
| 2019 FY | 45.11 Million USD | 3.08% |
| 2019 Q3 | 50.92 Million USD | 44.99% |
| 2018 Q1 | 53.34 Million USD | 150.96% |
| 2018 FY | 43.77 Million USD | 105.92% |
| 2018 Q3 | 44.91 Million USD | -8.39% |
| 2018 Q4 | 43.77 Million USD | -2.54% |
| 2018 Q2 | 49.02 Million USD | -8.1% |
| 2017 Q1 | 11.39 Million USD | -38.24% |
| 2017 FY | 21.25 Million USD | 15.18% |
| 2017 Q4 | 21.25 Million USD | 23.29% |
| 2017 Q3 | 17.24 Million USD | -12.09% |
| 2017 Q2 | 19.61 Million USD | 72.07% |
| 2016 Q1 | 39.75 Million USD | 0.78% |
| 2016 Q2 | 31.67 Million USD | -20.33% |
| 2016 Q3 | 23.18 Million USD | -26.79% |
| 2016 Q4 | 18.45 Million USD | -20.42% |
| 2016 FY | 18.45 Million USD | -53.22% |
| 2015 FY | 39.44 Million USD | 351.94% |
| 2015 Q1 | 7.66 Million USD | -12.17% |
| 2015 Q4 | 39.44 Million USD | -11.44% |
| 2015 Q3 | 44.54 Million USD | -9.67% |
| 2015 Q2 | 49.31 Million USD | 543.23% |
| 2014 Q4 | 8.72 Million USD | -27.94% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q2 | 5.32 Million USD | 0.0% |
| 2014 Q3 | 12.11 Million USD | 127.4% |
| 2014 FY | 8.72 Million USD | 98.47% |
| 2013 Q4 | 4.39 Million USD | 0.0% |
| 2013 FY | 4.39 Million USD | -47.85% |
| 2012 FY | 8.43 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -1300.918% |
| Arrayit Corporation | 1 Million USD | -1677.074% |
| Atlantic International Corp. | 4.43 Million USD | -300.726% |
| Biocept, Inc. | 30.87 Million USD | 42.417% |
| Bioqual, Inc. | 56.58 Million USD | 68.584% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -7565.029% |
| DermTech, Inc. | 121.93 Million USD | 85.42% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.575% |
| iMD Companies, Inc. | 190.13 Thousand USD | -9249.919% |
| IDenta Corp. | 1.52 Million USD | -1062.489% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -36.531% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -115.437% |
| InVitro International | 1.53 Million USD | -1058.903% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 33.759% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -768829.715% |
| Medical Imaging Corp. | 4.19 Million USD | -324.123% |
| NovelStem International Corp. | 2.25 Million USD | -688.525% |
| Optigenex Inc. | 1.88 Million USD | -841.468% |
| PharmChem, Inc. | 2.76 Million USD | -542.823% |
| Proteome Sciences plc | 14.58 Million USD | -21.881% |
| Response Genetics, Inc | 48.88 Million USD | 63.633% |
| Rennova Health, Inc. | 20.57 Million USD | 13.586% |
| RushNet, Inc. | 6.04 Million USD | -193.962% |
| ScreenPro Security Inc. | 1.26 Million USD | -1309.405% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -3663.08% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -2437.302% |
| Todos Medical Ltd. | 15.26 Million USD | -16.445% |